High-risk HLA allele mismatch combinations responsible for severe acute graft-versus-host disease and implication for its molecular mechanism
about
Choice of Unmanipulated T Cell Replete Graft for Haploidentical Stem Cell Transplant and Posttransplant Cyclophosphamide in Hematologic Malignancies in Adults: Peripheral Blood or Bone Marrow-Review of Published LiteratureHaploidentical Hematopoietic Stem Cell Transplantation: Expanding the Horizon for Hematologic DisordersHLA-C Incompatibilities in Allogeneic Unrelated Hematopoietic Stem Cell TransplantationAcute graft-versus-host disease: a bench-to-bedside update.Scripts for TRUMP data analyses. Part II (HLA-related data): statistical analyses specific for hematopoietic stem cell transplantation.Predicting alloreactivity in transplantation.Role of major histocompatibility complex variation in graft-versus-host disease after hematopoietic cell transplantation.Current and future approaches for control of graft-versus-host disease.Cross-reactivity of herpesvirus-specific CD8 T cell lines toward allogeneic class I MHC molecules.Genetic variants of human granzyme B predict transplant outcomes after HLA matched unrelated bone marrow transplantation for myeloid malignancies.A genetic variant in the IL-17 promoter is functionally associated with acute graft-versus-host disease after unrelated bone marrow transplantation.Allogeneic hematopoietic cell transplantation: the state of the artNonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation.High-resolution, high-throughput HLA genotyping by next-generation sequencing.Predicting HLA class I non-permissive amino acid residues substitutions.Nonmyeloablative HLA-haploidentical bone marrow transplantation with high-dose posttransplantation cyclophosphamide: effect of HLA disparity on outcomeGraft versus host disease in the bone marrow, liver and thymus humanized mouse model.The impact of HLA matching on unrelated donor hematopoietic stem cell transplantation in Korean children.HLA-C expression levels define permissible mismatches in hematopoietic cell transplantationThe impact of HLA and KIR ligand mismatching on unrelated allogeneic hematopoietic stem cell transplantation in Korean adult patientsDiversity of extended HLA-DRB1 haplotypes in the Finnish populationBiological significance of HLA locus matching in unrelated donor bone marrow transplantation.Identification by random forest method of HLA class I amino acid substitutions associated with lower survival at day 100 in unrelated donor hematopoietic cell transplantation.New advances in hematopoietic cell transplantationOptimal HLA matching in hematopoietic cell transplantation.Scoring HLA class I mismatches by HistoCheck does not predict clinical outcome in unrelated hematopoietic stem cell transplantation.Zooming into the binding groove of HLA molecules: which positions and which substitutions change peptide binding most?High HLA-DP Expression and Graft-versus-Host Disease.Outcomes of Nonmyeloablative HLA-Haploidentical Blood or Marrow Transplantation With High-Dose Post-Transplantation Cyclophosphamide in Older Adults.Role of HLA in Hematopoietic Stem Cell Transplantation.Unrelated hematopoietic stem cell donor matching probability and search algorithm.Three-dimensional structure discrepancy between HLA alleles for effective prediction of aGVHD severity and optimal selection of recipient-donor pairs: a proof-of-concept studyDonor registries and search strategiesGenetics of graft-versus-host disease: the major histocompatibility complex.Dissecting graft-versus-leukemia from graft-versus-host-disease using novel strategiesPaucity of HLA-identical unrelated donors for African-Americans with hematologic malignancies: the need for new donor options.HLA-A amino acid polymorphism and delayed kidney allograft function.Anti-thymocyte globulin for conditioning in matched unrelated donor hematopoietic cell transplantation provides comparable outcomes to matched related donor recipients.Hematopoietic transplantation from adult unrelated donors as treatment for acute myeloid leukemia.HLA-identical sibling compared with 8/8 matched and mismatched unrelated donor bone marrow transplant for chronic phase chronic myeloid leukemia.
P2860
Q26749454-F69455A5-0362-48FF-AB68-38D7DE1F249EQ26767501-FAF5BF2C-EFB7-4DA2-84BA-B9FDF2855816Q27022939-41DFC632-2F73-4F28-AA3D-5E6E436C0B1CQ27687130-00B774AF-ACDD-42B2-9A2B-75AB54996856Q31026869-1C6D7C8C-481B-4918-B6E3-9843C76A777CQ33608371-4BD53DC0-6FBB-4621-BEB0-42152320C124Q33642419-9A31F01A-B414-4816-B701-6B0B639210FEQ33642625-A8358BBB-F6F7-4554-8187-11E9C64C4CE0Q33658817-D86C726B-F46F-40BD-A791-28B683F1E4AAQ34008970-18F6295A-4E06-4A3C-B68E-2DE3861A766AQ34058468-2A8B17B0-48E0-4C39-8ACF-20BEDACB71A6Q34145155-CC6D2140-5BB7-464A-9401-B04D8E47E1AFQ34353744-D3CCB005-3330-43B9-9164-2EB93430BFFFQ34380961-13A4C366-3F44-4BB6-B859-50EEF5A27020Q34384277-62AC0F64-EC75-46FD-87F9-9F4112744C47Q34388640-53933360-B50C-4570-9BEC-F17A9DD65CADQ34408266-0FE9785D-ECF5-4EDB-A606-ADCC74D16C70Q34729272-1FB2A701-3BC8-4FD6-AC7A-851489903479Q34737555-CAD419B8-9925-4DDE-AB34-075E041510C3Q34749582-B347DE88-C0DB-4964-AD0C-27616F6EA7BCQ35053202-3002144E-021E-4DA3-A512-D0F4D49AD04EQ35080101-190F9125-C3D5-4CBA-9714-6A9A329A2459Q35082571-6527290C-7347-46B7-B3B8-9FD25C89F559Q35213018-1298DE19-533E-4D3B-A66E-8675BE1F9E4FQ35237720-F8F1D1A1-153A-4614-87E9-1B2A5384E2D8Q35723455-DD2221A9-69D7-4B8B-8F45-874600B3D4D4Q35837827-99691786-E769-40EB-AF24-E30E6960DDAAQ36028056-EA0D3AD1-F876-4249-B4E6-5B26FBDC238AQ36090971-42FF5F3E-C35C-4539-B9AA-7C8B15DABFD9Q36307305-452CDB38-E06B-4CDF-8416-CC30C7DC8D6BQ36413440-9B4E3AD2-ABAB-430F-B71B-9A3CC524A3C7Q36545617-4D0909A8-6F67-4A70-98C3-72679D789FF2Q36728745-0E741118-2552-45BD-AFC1-84FCBFD90A32Q36766250-2A411630-904B-462C-A0FD-7A99815BA9E5Q36819337-5F93F761-E455-45A5-885D-A2FD44452A21Q36914531-8B05A2FB-46BD-4AE0-A6B9-A04216062165Q37000024-EC55A553-CFFB-401D-84C9-5E509806A3BAQ37016397-8C9AA15E-268A-42B7-AFDE-F17E3FA5CE1DQ37061969-94B46DFD-7340-4E2E-9CE3-AE4416F119F4Q37158269-ADF7A3C7-5CE9-4D2C-A85F-CCA98CAB7886
P2860
High-risk HLA allele mismatch combinations responsible for severe acute graft-versus-host disease and implication for its molecular mechanism
description
im Oktober 2007 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 06 June 2007
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в жовтні 2007
@uk
name
High-risk HLA allele mismatch ...... on for its molecular mechanism
@en
High-risk HLA allele mismatch ...... on for its molecular mechanism
@nl
type
label
High-risk HLA allele mismatch ...... on for its molecular mechanism
@en
High-risk HLA allele mismatch ...... on for its molecular mechanism
@nl
prefLabel
High-risk HLA allele mismatch ...... on for its molecular mechanism
@en
High-risk HLA allele mismatch ...... on for its molecular mechanism
@nl
P2093
P1433
P1476
High-risk HLA allele mismatch ...... on for its molecular mechanism
@en
P2093
Hidetoshi Inoko
Hiroh Saji
Japan Marrow Donor Program
Koichi Kashiwase
Shunichi Kato
Takakazu Kawase
Takehiko Sasazuki
Takeo Juji
Yasuo Morishima
Yoshihisa Kodera
P304
P356
10.1182/BLOOD-2007-02-072405
P407
P577
2007-06-06T00:00:00Z